Product code SCZ— Cardiovascular

ShortCut

Classification name
Percutaneous Catheter For Cutting Or Splitting Heart Valve Leaflets Concomitant To Transcatheter Valve Procedures
Device class
Class 2
Regulation
21 CFR 870.1254
Advisory panel
Cardiovascular
Total cleared
1
First cleared
Most recent

FDA classification definition

“The device is a single use percutaneous catheter system intended for mechanically splitting aortic valve leaflets that may prevent coronary artery ostia obstruction during planned transcatheter valve procedures.”

— U.S. Food and Drug Administration, device classification record for product code SCZ under 21 CFR 870.1254, via openFDA

Market context for product code SCZ

FDA has cleared 1 device under product code SCZ, all in 2024, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code SCZ

Adverse events under product code SCZ

product code SCZ
Death
4
Total
4

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code SCZ

Data sourced from openFDA. This site is unofficial and independent of the FDA.